V

Viosera Therapeutics

10 employees

Viosera Therapeutics is a predict and block drug resistance in cancer and bacteria.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Therapeutics
Wellness
Medical
Pharmaceutical

Date founded

2016

Funding rounds raised

Total raised

$150K

from 7 investors over 7 rounds

V

Viosera Therapeutics raised undisclosed on June 1, 2019

Investors: Brightstone Venture Capital and UpHonest Capital

V

Viosera Therapeutics raised $150K on March 18, 2019

Investors: Endpoint Ventures, SV Angel, Pioneer Fund and Y Combinator

V

Viosera Therapeutics raised undisclosed on December 1, 2018

Investors: St. Louis Arch Angels

FAQ